See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.69▲ 1.79%
← VMX page
XStocksXray
Market X-Ray report · 27 October 2026

Verimatrix (VMX)

Euronext Paris · France · prices in EUR · close of 27 Oct 2026

Key indicators

Last closeEUR 0.277
52-week range0.144 – 0.377
Return, 1 month / 3 months−9.8% / +24.8%
Return, 1 year / 3 years+63.9% / −34.8%
TrendAbove 200-day, below 50-day
RSI (14)46
Volatility (1 year)57.3%
Worst drawdown (1 year)-33.8%
Average daily value traded0.05M EUR
Dividend yield–

Market X-Ray price-based

71/ 100 · High confidence · ahead of 86% of stocks on this exchange
Trend83
Momentum96
Stability (higher is calmer)43
Liquidity55
Income–

Five-year price chart navy: price · brown: 200-day average

0.070.410.741.081.412021-112023-022024-052025-082026-10

About the company

Verimatrix is a software company that supplies security technology for video services and connected devices. It provides conditional access, digital rights management and watermarking tools that help pay-television operators, streaming providers and device makers protect content and manage how it is delivered to viewers. The company is based in France and works with customers around the world who distribute television and video over broadcast, internet and mobile networks.

Verimatrix trades under the code VMX on the Euronext Paris in France, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Verimatrix (VMX) trades on the Euronext Paris in France. It last closed at EUR 0.277 on 27 October 2026.

Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 90 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 63.9% and over the last three months it rose 24.8%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Verimatrix (VMX)

The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris

Lens and metricValueScoreReading
Trend83 · StrongTrading above its long-term averages and near its highs.
Above 200-day average20.6%
From 52-week high-25.1%
Momentum96 · StrongRising faster than most stocks on this exchange.
3-month return24.8%
6-month return62.5%
12-month return, skipping the last month81.7%
Stability (higher is calmer)43 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)57.3%
Worst drawdown, 1 year (smaller is calmer)-33.8%
Liquidity55 · FairModerate trading activity.
Average daily value traded0.05M EUR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+8.2%
1 month−9.8%
3 months+24.8%
6 months+62.5%
1 year+63.9%
3 years−34.8%
5 years−77.2%

Signals

50-day / 200-day average0.312 / 0.230
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.012

Technical summary

DailyNeutral6 bullish · 4 neutral · 6 bearish
WeeklyBullish7 bullish · 1 neutral · 4 bearish
MonthlyBullish5 bullish · 1 neutral · 2 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026